Printer Friendly

ECHOCARDIOGRAPHIC STUDY OF CARDIAC DYSFUNCTION IN PATIENTS OF CHRONIC KIDNEY DISEASE ON HEMODIALYSIS.

Byline: Shahana Arshi, Ghias-ud-Din Butt and Fazalul Aziz Mian

Abstract

Objective: The objective of this study was to see echocardiographic findings of cardiac dysfunction in patients of chronic kidney disease (CKD) on hemodialysis.

Study Design: Comparative cross sectional study.

Place and Duration of Study: Department of nephrology, Pakistan Institute of Medical Sciences. Islamabad from September 2014 to February 2015.

Patients and Methods: One hundred patients of either gender were included in this study. Fifty patients of chronic kidney disease stage V on hemodialysis were taken for echocardiography and fifty were normal. Echocardiography was done for cardiac dysfunction. Systolic function was measured by ejection fraction (EF) and fractional shortening (FS). Diastolic function was measured by E/A ratio.

Results: Out of 100 patients included in the study, 50 patients were on hemodialysis and 50 were control. Left ventricular end systolic and end diastolic volumes were higher in patients on hemodialysis than controls as well as left atrial enlargement and inter ventricular septum which was statistically significant. Ejection fraction, although normal and fractional shortening decreased in patients on hemodialysis (p<0.05). Diastolic dysfunction was present in 36 patients on hemodialysis, while absent in the control group.

Conclusion: Patients with chronic kidney disease on hemodialysis have higher prevalence of cardiac dysfunction.

Keywords: Diastolic dysfunction, Echocardiography, Hemodialysis.

INTRODUCTION

CKD Patients have increased risk for cardiovascular disease (CVD). Ten to 30 fold increased cardiovascular mortality risk is present in dialysis patients as compared with the general population, and had 44% of overall mortality1. Evidence is present which indicates that a portion of this cardiovascular damage may be due to hemodialysis (HD). HD causes hemodynamic instability through the development of subclinical myocardial ischemia2. In another study, cardiac arrhythmias are caused by abnormal ventricular morphology and function in patients3. Cardiac function is routinely measured using diagnostic imaging techniques. Echocardiography (ECHO) is one method for assessment of cardiac dysfunction2.

Echocardiography and tissue doppler analysis provide additional diagnostic data on ventricular function4. Presently, the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/e' ratio) is used for the evaluation of LV filling pressure, and it has been used as a marker to diagnose diastolic HF5,6. The prevalence of left ventricular systolic and diastolic dysfunction is less clear. Cardiac disease usually presents before dialysis and cardiac dysfunction is common7. The present study was aimed at assessing the prevalence of cardiac dysfunctions by echocardiography in patients on hemodialysis.

PATIENTS AND METHODS

This comparative cross sectional study was conducted at department of Nephrology, Pakistan Institute of Medical Sciences Islamabad for a period of six months from September 2014 to February 2015. In this study 100 patients, 50 from CKD stage V and 50 normal persons were taken through non probability consecutive sampling. The sample size was calculated using Open Epi sample size calculator version 2.3. Patients aged 15 to 70 with CKD V on hemodialysis were included, who had no history of cardiac disease or symptoms. Patients fulfilling the aforesaid criteria were enrolled in the study and informed consent was obtained. Vital signs were recorded. For checking cardiac status, clinical examination was done. Patients with already known cardiac disease were excluded. The purpose of study was explained to all the patients. All patients were in dialysis unit and echocardiography and investigations were done in OPD.

Echocardiography was done by consultant cardiologist by cardiology department, Pakistan Institute of Medical Sciences (PIMS). All findings were noted and record was kept. Left ventricular systolic function was taken as LVEF and fractional shortening (FS). E/A ratio showed diastolic dysfunction. E is peak early diastole velocity and A is peak atrial filling velocity of left ventricle across mitral valve. E/A ratio <0.75 and more than 1.8 was considered as diastolic dysfunction. Fractional shortening normal range was 25% to 45%. Ejection fraction was taken normal = 59.2 +- 6%. There are three echocardiographic patterns of diastolic heart failure. The mildest form is called an "abnormal relaxation pattern", or grade I diastolic dysfunction. On the mitral inflow doppler echocardiogram, there is reversal of the normal E/A ratio. Grade II diastolic dysfunction is called "pseudonormal filling dynamics". This is considered moderate diastolic dysfunction.

Grade III and IV diastolic dysfunction are called "restrictive filling dynamics". Both of these are severe forms of diastolic dysfunction. The data from patients were collected on a proforma. Statistical analysis was done by SPSS software version 16. All data were tabulated and analyzed. Cardiac dysfunction was expressed as mean +- standard deviation. To test for differences in mean values between two groups student's t-test was used. p value < 0.05 was condidered significant.

RESULTS

A total of 100 patients were included in the study according to inclusion criteria. Fifty patients were on hemodialysis and 50 were controls. The mean age of patients on dialysis was 39.5 years (SD=14.1) and 35.7 years (SD=17) in the control group. Twenty seven patients (54%) were males and twenty three (46%) were females in patients on hemodialysis with male to female ratio of 1:1.17, while twenty five (50%) were males and twenty five (50%) were females with male to female ratio was 1:1 (table-I) in the control group. Distribution of patients in two groups with respect to echocardiographic parameters were given in table-II. Left ventricular end systolic and end diastolic volume were higher in patients on hemodialysis than controls as well as left atrial enlargement and inter ventricular septum which were statistically significant.

Ejection fraction, although normal and fractional shortening decreased in patients on hemodialys is (p-value <0.05). Diastolic dysfunction was present in 36 patients on hemodialysis, while absent in control group (table-III).

DISCUSSION

The analysis of echocardiographic findings in this study showed that CKD in patients on hemodialysis was associated with a significant increase in both systolic and diastolic left ventricular dimensions. In one study, 30% patients had EF <50% which was significantly different from controls7. In our study, patients on hemodialysis EF was 65% and control had 56%. In this study, there was no difference in the mean fractional shortening among the two groups i.e, control and patients on hemodialysis. Raj et al (1997) found fractional shortening (FS) in dialysis patients to be 33.3 +- 13.0%, while in controls it was 33 +- 9.3%. FS in dialysis patients were 31.7 +- 7.9% and it was control is 36.2 +- 6.0% in our study8. In a study by Greaves et al, FS showed a trend from being highest in the controls (36.5 +- 5.6%), and lowest in the dialysed patients (29.8 +- 8.9%) and LV systolic function generally preserved9.

Harnett et al, found a mean FS of 35 +- 6, only 4% patients had systolic dysfunction. All these studies showed that fractional shortening is good in CRF patients7. According to studies the occurrence of systolic dysfunction of LV varies from 15% to 28% in patients on dialysis.

Table-I: Age and sex distribution among the study group.

###Control (n=50)###Patients on dialysis (n=50)

###Mean +- SD###35.7 +- 17 years###39.5 +- 14.1 years

Age

###Range###10-85 years###18-65 years

###Male###25 (50%)###27 (54%)

Sex

###Female###25 (50%)###23 (46%)

Table-II: Distribution of patients by echocardiographic measures among the study group.

Echocardiographic Parameters###Control (n=50)###Patients on dialysis###p-value

###(n=50)

LVES, (mm)###27.4 +- 4.5###36.2 +- 5.9###<.001

LVED, (mm)###43 +- 4.8###52.4 +- 4###<.001

Left atrial Enlargement, (mm)###27.7+- 4.4###35.2 +- 7.3###<.001

IVS, (mm)###9.1 +- 1.1###11.6 +- 2.2###<.001

EF (%)###65.4 +- 4.8###56 +- 10.4###<.001

FS (%)###36.2 +- 6.0###31.7 +- 7.9###<.002

Table-III: Diastolic dysfunction among the study group.

###Control (n=50)###Patients on dialysis (n=50)

Absent###50 (100%)###14 (25%)

Mild###0###21 (42%)

Moderate###0###15 (30%)

Severe###Nil###Nil

In our study, systolic dysfunction was present in hemodialysis patients as compared to controls. p-value <0.05)10. Left ventricular diastolic dysfunction is an important cause of cardiac morbidity in end stage renal disease (ESRD) patients. Diastolic dysfunction appears to be the initial left ventricular dysfunction and might even precede left ventricular hypertrophy11. In the present study, the mean E/A ratio in control group was 1.5 (normal). One study reported a significant reduction in E/A ratio in haemodialysis patients as compared to controls as in ours12. A study, conducted on patients on dialysis showed that diastolic velocities were 'relatively' independent of preload, did not significantly change after one session of hemodialysis and therefore E' parameter can be particularly useful for dialysis patients to differentiate between pseudonormalization and normal diastolic function profile13.

The analysis of LV diastolic parameters on the basis of E/A ratio was significantly higher in dialysis patients. Also in another study E velocity was significantly lower in healthy subjects and CKD patients stage II-IV (p<0.01-0.02) compared to stage V and E/A and E' could help to differentiate between healthy subjects and patients with early stage of CKD. In this study, E/A ratio did not differ before and after the dialysis14. According to other studies the incidence of diastolic LV dysfunction in CKD ranges from 50% to 65% including patients non-dialysed, those on dialysis and renal transplant recipients where as in our study it was 72%15. One study showed that LV diastolic function may influence the increase in left ventricular preload as a result of CKD progression. Therefore, LV hypertrophy may be a better prognostic factor than the LV diastolic dysfunction in predicting low eGFR in patients with CKD.

The increase in diastolic LV dimension observed in this study as well as very high prevalence of CKD-associated diastolic dysfunction may be an indicator of left ventricular volume overload which is due to over-hydration16. Chronic effects of HD on LV diastolic function is unclearly. Studies were reported different results: a significant alterations at LV longitudinal myocardial function parameters assessed by color doppler, improved indices for left ventricular diastolic function and did not change Doppler parameters of mitral inflow17,18. During ventricular diastole the LA is directly exposed to LV filling pressure. Therefore, increased LA size and volume may reflect the duration and severity of diastolic dysfunction. Effect of HD on LA dimension could be explained by the factors that influence LV filling. Left atrial pressure increases and results in augmented LA dimensions whenever preload increases and/or LV compliance decreases.

In patients undergoing HD, the LA parameters reported as a marker of chronic diastolic dysfunction, however some investigators showed that LA parameters were similar in the group of healthy volunteers. The mean LA dimension was significantly higher after HD treatment than base line value. Myocardial velocity was relatively preload independent measurements of diastolic function and more accurately reflects LV diastolic dysfunction. In patients with ESRD, because of the renal anemia, systemic hypertension, volume overload, and the presence of an AVF with high-flow rates, LV systolic and diastolic diameters, wall thickness and cardiac output are increased and indirectly EF is decreased. Several studies have shown that patients with ESRD before and on dialysis had higher LV volumes and dimensions. Increases in LVEDD, LVESD were found after maintenance HD treatment in that study.

In that study, 2% decrease in ejection fraction was observed following the HD treatment. In our study, EF decreased19.

One study, showed that HD treatment was associated with significant reductions in myocardial blood flow. Stress-induced myocardial ischemia occurs in the absence of large-vessel epicardial coronary disease and repetitive episodes of ischemia may lead to LV systolic dysfunction20. Another study showed that the long-term effects of HD on LV and RV functions were insignificant in patients with end-stage renal disease. We have demonstrated that the LV and RV functions did not change significantly after long-term HD treatment. But in our study, cardiac dysfunction present21. In NP singh study,LVH was 76.92%, 72% diastolic dysfunction was 72% but systolic dysfunction not present in CKD patients22..

Agarwal study showed diastolic dysfunction in 60% and systolic dysfunction in 15%, as in our study 72% had mild and moderate diastolic dysfunction7. Seventeen cases (48%) had diastolic dysfunction, 11 (29%) systolic dysfunction, 8 (18%) had normal echocardiogram and 2 (5%) had dilated left ventricle with normal ejection fraction23. In more than half of the patients increased left ventricle end-diastolic dimension and worsening of diastolic function (shortening of deceleration time, E wave, the increase in E/A) were observed as in our study24.

There are several limitations of this study. We did not perform any routine follow-up of the patients. Our study was performed on a relatively small population (n=50), but still can be compared to previous studies in the field. The study was shown that there is a need for further studies for cardiac status and prognosis of patients.

CONCLUSION

The present study shows that there is high prevalence of cardiac dysfunction in hemodialysis patients.

CONFLICTOF INTEREST

This study has no conflict of interest to declare by any author.

REFERENCES

1. Laddha M, Sachdeva V, Diggikar PM, Satpathy PK, Kakrani AL. Echocardiographic assessment of cardiac dysfunction in patients of end stage renal disease on haemodialysis.J Asso Physicians India. 2014; 62(1):28-32.

2. Sag S, Yesilbursa D, Yildiz A, Dilek k, Senturk T, Serdar OA et al. Acute Haemodialysis-induced Changes in Tissue Doppler echocardiography Parameters.Balkan Med J 2014; 31: 239-43.

3. Voroneanu L, Covic A. Arrhythmias in hemodialysis patients. J Nephrol. 2009; 22(6): 716-25.

4. Bruch C, Rothenburger M, Gotzmann M, Wichter T, Scheld HH, Breithardt G, et al. Chronic kidney disease in patients with chronic heart failure: impact on intracardiac conduction, diastolicfunction and prognosis. Int J Cardiol 2007; 118(3): 375-80.

5. Hillis GS, Moller JE, Pellikka PA, Gerish BJ, Wright RS, Ommen SR, et al. Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2014; 43: 360-7.

6. Maeder MT, Ammann P, Rickli H. The diagnosis of heart failure with normal ejection fraction: a demanding task!. Swiss Med Wkly. 2010; 140: 323.

7. Agarwal S, Dangri P, Kalra OP, Rajpal S. Echocardiographic assessment of cardiac dysfunction in patients of chronic renal failure. JIACM 2013; 4: 296-303.

8. Raj DSG, D'Mello S, Somiah S, Sheeba SD, Mani K. Left ventricular morphology in chronic renal failure by echocardiography. Renal Failure 1997; 19 (6): 799-806.

9. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN. Determinants of left ventricular hypertrophy and systolic dysfunction inchronic renal failure. Am J Kidney Dis 2004; 24: 768-76.

10. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996; 49(5): 1428-34.

11. Schroeder AP, Kristensen BO, Neilsen CB, Pedersen EB. Heart function in patients with chronic glomerulonephritis and mildly to moderately impaired renal function. Blood Press 2007; 6: 286-93.

12. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B. Cardiac hypertrophy and arterial alteration in end-stage renal disease: hemodynamic factors. Kidney Int 1993; 41: S42-9.

13. Barberato SH, Mantilla DE, Misocami MA, Goncalves SM, Bignelli AT, Riella MC, et al. Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. Am J Cardiol. 2004; 1; 94(9): 1208-10.

14. Otsuka T, Suzuki M, Yoshikawa H, Sugi KJ Cardiol. Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. 2009; 54(2): 199-204.

15. Crews DC, Plantinga LC, Miller ER 3rd, Saran R, Hedgeman E, Saydah SH, et al. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension. 2010; 55(5): 1102-9.

16. Masugata H, Senda S, Goda F, Yamagami A, Okuyama H, Kohno T, et al. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?. Clin Exp Hypertens. 2010; 32(2):113-20.

17. Gulel O, Soylu K, Yuksel S, Karaoglanoglu M, Cengiz K, Dilek M, et al. Evidence of left ventricular systolic and diastolic dysfunction by color tissue Doppler imaging despite normal ejection fraction in patients on chronic hemodialysis program. Echocardiography. 2008; 25(6): 569-74.

18. Fijalkowski M, Koprowski A, Gruchala M, Galaska R, Debska- Slizien A, Rogowski J, et al. Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end- stage renal disease. J Am Soc Echocardiogr. 2006; 19(11): 1359-64.

19. Duran M, Unal A, Inanc MT, Esin F, Yilmaz Y, Omek E. Effect of maintenance hemodialysis on diastolic left ventricular function in end stage renal disease. Clinics. 2010; 65(10): 979-84.

20. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008; 3(1):19-26.

21. Hemodialysis does not impair ventricular functions over 2 years. Duran M, Unal A, Inanc MT, Kocyigit l, Oguz F, Ocak A, et al. Hemodial Int. 2011; 15(3): 334-40.

22. Singh NP, Chandrashekar, Nair M, Anuradha S, Kohli R, Agarwal SK. The cardiovascular andhemodynamic effects of erythropoietin in CRF. JAPI 2000; 48: 301-306.

23. Yazdani I, Ahmed S, Yaqoob Z. Evaluation of the effect of hemodialysis on cardiac dysfunction in patients of chronic renal failure.J Pak Med Assoc.1998; 48(8):230-2.

24. Skora BF, Gluba A, Olszewski R, Banach M, Rysz J. Heart function disturbances in chronic kidney disease- echocardiographic indices. Arch Med Sci. 2014; 10(6): 1109-16.
COPYRIGHT 2016 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Pakistan Armed Forces Medical Journal
Article Type:Clinical report
Date:Dec 31, 2016
Words:3162
Previous Article:BURNOUT AMONG FEMALE NURSING STUDENTS.
Next Article:ROLE OF UTERINE ARTERY DOPPLER ULTRASOUND IN PREDICTING PRE-ECLAMPSIA IN PRIMIGRAVIDA.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters